What Researchers Did
Researchers described the successful treatment of 4 patients with Raynaud's phenomenon associated with systemic sclerosis, 3 of whom had ischemic ulcers, using hyperbaric oxygen therapy.
What They Found
All 4 patients with Raynaud's phenomenon associated with systemic sclerosis, including 3 with ischemic ulcers, were successfully treated with hyperbaric oxygen. This therapy demonstrated usefulness in treating chronic wounds due to its anti-inflammatory, antimicrobial, and angiogenic effects.
What This Means for Canadian Patients
Hyperbaric oxygen therapy might offer a new treatment option for Canadian patients suffering from Raynaud's phenomenon associated with systemic sclerosis, especially those with refractory symptoms or ischemic ulcers. Patients who have not responded to conventional treatments could discuss hyperbaric oxygen therapy with their healthcare providers as a potential alternative.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A major limitation of this study is its small sample size, describing only 4 patients, which limits the generalizability of the findings.